Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murat Ak

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Neuro-Oncology|June 2, 2025
Radiogenomics and radiomics of skull base chordoma: Classification of novel radiomic subgroups and prediction of genetic signatures and clinical outcomesZachary C Gersey, Serafettin Zenkin, Priyadarshini Mamindla, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2024
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLCDiego de Miguel-Perez, Murat Ak, Priyadarshini Mamindla, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Author response to Cunha <i>et al</i>Rivka R Colen, Christian Rolfo, Murat Ak, et al.
Journal for Immunotherapy of Cancer|April 14, 2021
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersRivka R Colen, Christian Rolfo, Murat Ak, et al.
World Neurosurgery|January 22, 2024
Associating T1-Weighted and T2-Weighted Magnetic Resonance Imaging Radiomic Signatures With Preoperative Symptom Severity in Patients With Cervical Spondylotic MyelopathyNima Alan, Serafettin Zenkin, Raj Swaroop Lavadi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanomaAlexandra Tompkins, Zane N Gray, Rebekah E Dadey, et al.
Ebiomedicine|September 16, 2021
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in gliomaAlexandra Foster, Shubhanchi Nigam, David S Tatum, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanomaAlexandra G Tompkins, Zane N Gray, Rebekah E Dadey, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancerDiego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.
Neuro-Oncology|December 12, 2024
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter studyHamed Akbari, Spyridon Bakas, Chiharu Sako, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Neuro-Oncology|June 2, 2025
Radiogenomics and radiomics of skull base chordoma: Classification of novel radiomic subgroups and prediction of genetic signatures and clinical outcomesZachary C Gersey, Serafettin Zenkin, Priyadarshini Mamindla, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 15, 2024
Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLCDiego de Miguel-Perez, Murat Ak, Priyadarshini Mamindla, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Author response to Cunha <i>et al</i>Rivka R Colen, Christian Rolfo, Murat Ak, et al.
Journal for Immunotherapy of Cancer|April 14, 2021
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersRivka R Colen, Christian Rolfo, Murat Ak, et al.
World Neurosurgery|January 22, 2024
Associating T1-Weighted and T2-Weighted Magnetic Resonance Imaging Radiomic Signatures With Preoperative Symptom Severity in Patients With Cervical Spondylotic MyelopathyNima Alan, Serafettin Zenkin, Raj Swaroop Lavadi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2024
Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanomaAlexandra Tompkins, Zane N Gray, Rebekah E Dadey, et al.
Ebiomedicine|September 16, 2021
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in gliomaAlexandra Foster, Shubhanchi Nigam, David S Tatum, et al.
Journal for Immunotherapy of Cancer|February 12, 2025
Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanomaAlexandra G Tompkins, Zane N Gray, Rebekah E Dadey, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancerDiego de Miguel-Perez, Alessandro Russo, Oscar Arrieta, et al.
Neuro-Oncology|December 12, 2024
Machine learning-based prognostic subgrouping of glioblastoma: A multicenter studyHamed Akbari, Spyridon Bakas, Chiharu Sako, et al.
Pageof 3